Building companies that transform healthcare
We build companies that compress time-to-market, time-to-impact and time-to-return
We’re building an ecosystem of healthtech companies across five investment theses
Automating Workflows
Improving efficiency and quality by redesigning healthcare workflows with AI
Creating New Biomarkers
Transforming disease detection and monitoring with AI and novel biomarkers
Reimagining Consumer Experiences
Reimagining how patients access, navigate, and engage with healthcare
Unlocking Real-World Data
Accelerating drug development and optimizing treatments with real-world data
Expanding Share of Care
Building innovative care models that drive continuity across the patient journey
The four ways we create industry-defining companies
De Novo
We launch new companies around a secular thesis and bring them to life through our venture creation process
Asset Acquisitions
We acquire foundational IP, data, and customer relationships to launch new AI-native businesses
Spinouts
We spin out scaled enterprise business units into tech-enabled companies to serve broader market demand
Partnering with Leading Scientists
We partner with top researchers to productize, commercialize, and scale their groundbreaking discoveries
